Published in Nat Genet on October 10, 2016
Vitiligo blood transcriptomics provides new insights into disease mechanisms and identifies potential novel therapeutic targets. BMC Genomics (2017) 0.75
Genetics of Vitiligo. Dermatol Clin (2017) 0.75
PLINK: a tool set for whole-genome association and population-based linkage analyses. Am J Hum Genet (2007) 209.92
Measuring inconsistency in meta-analyses. BMJ (2003) 128.20
Principal components analysis corrects for stratification in genome-wide association studies. Nat Genet (2006) 115.71
Quantifying heterogeneity in a meta-analysis. Stat Med (2002) 83.16
Genome-wide meta-analysis increases to 71 the number of confirmed Crohn's disease susceptibility loci. Nat Genet (2010) 17.38
STRING v10: protein-protein interaction networks, integrated over the tree of life. Nucleic Acids Res (2014) 10.79
Trait-associated SNPs are more likely to be eQTLs: annotation to enhance discovery from GWAS. PLoS Genet (2010) 10.75
Multiple common variants for celiac disease influencing immune gene expression. Nat Genet (2010) 6.90
Genome-wide association study in a Chinese Han population identifies nine new susceptibility loci for systemic lupus erythematosus. Nat Genet (2009) 6.42
NALP1 in vitiligo-associated multiple autoimmune disease. N Engl J Med (2007) 3.99
g:Profiler--a web server for functional interpretation of gene lists (2011 update). Nucleic Acids Res (2011) 3.94
Human B7-1 (CD80) and B7-2 (CD86) bind with similar avidities but distinct kinetics to CD28 and CTLA-4 receptors. Immunity (1994) 3.73
REL, encoding a member of the NF-kappaB family of transcription factors, is a newly defined risk locus for rheumatoid arthritis. Nat Genet (2009) 3.36
Defining functional DNA elements in the human genome. Proc Natl Acad Sci U S A (2014) 3.35
PANTHER version 10: expanded protein families and functions, and analysis tools. Nucleic Acids Res (2015) 3.35
Transcriptional enhancers: from properties to genome-wide predictions. Nat Rev Genet (2014) 3.16
Innate immune activity conditions the effect of regulatory variants upon monocyte gene expression. Science (2014) 3.16
Epidemiology of vitiligo and associated autoimmune diseases in Caucasian probands and their families. Pigment Cell Res (2003) 3.07
Discovering genetic ancestry using spectral graph theory. Genet Epidemiol (2010) 3.03
Genome-wide association study in alopecia areata implicates both innate and adaptive immunity. Nature (2010) 2.85
Eos mediates Foxp3-dependent gene silencing in CD4+ regulatory T cells. Science (2009) 2.76
Partitioning heritability of regulatory and cell-type-specific variants across 11 common diseases. Am J Hum Genet (2014) 2.53
Variant of TYR and autoimmunity susceptibility loci in generalized vitiligo. N Engl J Med (2010) 2.47
Genome-wide association analysis of autoantibody positivity in type 1 diabetes cases. PLoS Genet (2011) 2.25
Partitioning heritability by functional annotation using genome-wide association summary statistics. Nat Genet (2015) 2.05
A genome-wide association study identifies two new risk loci for Graves' disease. Nat Genet (2011) 1.92
Identification of a susceptibility locus in STAT4 for Behçet's disease in Han Chinese in a genome-wide association study. Arthritis Rheum (2012) 1.84
A gene-based association method for mapping traits using reference transcriptome data. Nat Genet (2015) 1.82
Genome-wide association analyses identify 13 new susceptibility loci for generalized vitiligo. Nat Genet (2012) 1.81
A cytosolic granzyme B inhibitor related to the viral apoptotic regulator cytokine response modifier A is present in cytotoxic lymphocytes. J Biol Chem (1996) 1.75
A polymorphism in IRF4 affects human pigmentation through a tyrosinase-dependent MITF/TFAP2A pathway. Cell (2013) 1.75
Bayesian test for colocalisation between pairs of genetic association studies using summary statistics. PLoS Genet (2014) 1.71
The definition and assessment of vitiligo: a consensus report of the Vitiligo European Task Force. Pigment Cell Res (2007) 1.57
A genome-wide association study of myasthenia gravis. JAMA Neurol (2015) 1.52
Genome-wide association study of tanning phenotype in a population of European ancestry. J Invest Dermatol (2009) 1.50
Early disease onset and increased risk of other autoimmune diseases in familial generalized vitiligo. Pigment Cell Res (2005) 1.50
Novel associations for hypothyroidism include known autoimmune risk loci. PLoS One (2012) 1.50
Meta-analysis followed by replication identifies loci in or near CDKN1B, TET3, CD80, DRAM1, and ARID5B as associated with systemic lupus erythematosus in Asians. Am J Hum Genet (2012) 1.49
Genome-wide association analysis in primary sclerosing cholangitis identifies two non-HLA susceptibility loci. Nat Genet (2010) 1.43
Vitiligo-like depigmentation in patients with stage III-IV melanoma receiving immunotherapy and its association with survival: a systematic review and meta-analysis. J Clin Oncol (2015) 1.42
Bcl2L12 inhibits post-mitochondrial apoptosis signaling in glioblastoma. Genes Dev (2007) 1.38
Common variants in FOXP1 are associated with generalized vitiligo. Nat Genet (2010) 1.25
Interaction of Agouti protein with the melanocortin 1 receptor in vitro and in vivo. Genes Dev (1998) 1.25
A genome-wide association study in Han Chinese identifies a susceptibility locus for primary Sjögren's syndrome at 7q11.23. Nat Genet (2013) 1.19
PGC-1 coactivators regulate MITF and the tanning response. Mol Cell (2012) 1.07
Next-generation DNA re-sequencing identifies common variants of TYR and HLA-A that modulate the risk of generalized vitiligo via antigen presentation. J Invest Dermatol (2012) 1.07
The genetics of generalized vitiligo: autoimmune pathways and an inverse relationship with malignant melanoma. Genome Med (2010) 1.07
Functional interpretation of non-coding sequence variation: concepts and challenges. Bioessays (2013) 1.06
Accounting for eXentricities: analysis of the X chromosome in GWAS reveals X-linked genes implicated in autoimmune diseases. PLoS One (2014) 1.04
Genome-wide pathway analysis of genome-wide association studies on systemic lupus erythematosus and rheumatoid arthritis. Mol Biol Rep (2012) 1.03
Genome-wide association scan in north Indians reveals three novel HLA-independent risk loci for ulcerative colitis. Gut (2014) 1.02
A symbiotic concept of autoimmunity and tumour immunity: lessons from vitiligo. Trends Immunol (2001) 1.00
Enhancer variants: evaluating functions in common disease. Genome Med (2014) 0.95
Integration of disease association and eQTL data using a Bayesian colocalisation approach highlights six candidate causal genes in immune-mediated diseases. Hum Mol Genet (2015) 0.94
Mapping of immune-mediated disease genes. Annu Rev Genomics Hum Genet (2013) 0.93
MUM1/IRF4: A Review. Appl Immunohistochem Mol Morphol (2010) 0.93
Melanoma genetics. J Med Genet (2015) 0.90
BimL directly neutralizes Bcl-xL to promote Bax activation during UV-induced apoptosis. FEBS Lett (2009) 0.88
RANKL-RANK interaction in immune regulatory systems. World J Orthop (2012) 0.85
Genetics of skin color variation in Europeans: genome-wide association studies with functional follow-up. Hum Genet (2015) 0.85
Multiple Changes of Gene Expression and Function Reveal Genomic and Phenotypic Complexity in SLE-like Disease. PLoS Genet (2015) 0.83
Allele-specific transcriptional regulation of IRF4 in melanocytes is mediated by chromatin looping of the intronic rs12203592 enhancer to the IRF4 promoter. Hum Mol Genet (2015) 0.82
Decreased risk of melanoma and nonmelanoma skin cancer in patients with vitiligo: a survey among 1307 patients and their partners. Br J Dermatol (2013) 0.81
Re-Annotator: Annotation Pipeline for Microarray Probe Sequences. PLoS One (2015) 0.79
Risk of generalized vitiligo is associated with the common 55R-94A-247H variant haplotype of GZMB (encoding granzyme B). J Invest Dermatol (2013) 0.79
Autoimmune vitiligo is associated with gain-of-function by a transcriptional regulator that elevates expression of HLA-A*02:01 in vivo. Proc Natl Acad Sci U S A (2016) 0.79
MHC class II super-enhancer increases surface expression of HLA-DR and HLA-DQ and affects cytokine production in autoimmune vitiligo. Proc Natl Acad Sci U S A (2016) 0.78
Markedly reduced incidence of melanoma and nonmelanoma skin cancer in a nonconcurrent cohort of 10,040 patients with vitiligo. J Am Acad Dermatol (2014) 0.77
TSG-6 released from intradermally injected mesenchymal stem cells accelerates wound healing and reduces tissue fibrosis in murine full-thickness skin wounds. J Invest Dermatol (2013) 1.47
Scientific and regulatory issues related to indoor tanning. J Am Acad Dermatol (2004) 1.42
Adverse effects of ultraviolet radiation from the use of indoor tanning equipment: time to ban the tan. J Am Acad Dermatol (2011) 1.41
Elevated ΔNp63α Levels Facilitate Epidermal and Biliary Oncogenic Transformation. J Invest Dermatol (2016) 1.41
Is Nox4 a key regulator of the activated state of fibroblasts in systemic sclerosis? Exp Dermatol (2014) 1.40
Genome-wide meta-analysis in alopecia areata resolves HLA associations and reveals two new susceptibility loci. Nat Commun (2015) 1.32
Vitiligo. Lancet (2015) 1.27
Adverse effects of ultraviolet radiation from the use of indoor tanning equipment: time to ban the tan. J Am Acad Dermatol (2011) 1.06
Pathogenesis of photosensitivity in the cutaneous porphyrias. J Invest Dermatol (2005) 0.91
Hypomelanoses in children. J Cutan Aesthet Surg (2013) 0.87
Palmoplantar Pustular Psoriasis Is Associated with Missense Variants in CARD14, but Not with Loss-of-Function Mutations in IL36RN in European Patients. J Invest Dermatol (2015) 0.83
Targeting of NADPH oxidase in vitro and in vivo suppresses fibroblast activation and experimental skin fibrosis. Exp Dermatol (2017) 0.78
An α-MSH analog in erythropoietic protoporphyria. J Invest Dermatol (2015) 0.76
Targeting CTLA-4, PD-L1 and IDO to modulate immune responses in vitiligo. Exp Dermatol (2016) 0.76
Evaluation of an oral supplement containing Phyllanthus emblica fruit extracts, vitamin E, and carotenoids in vitiligo treatment. Dermatol Ther (2014) 0.76
Immunochip-based analysis: high-density genotyping of immune-related loci sheds further light on the autoimmune genetic architecture of alopecia areata. J Invest Dermatol (2014) 0.76
Genomewide analysis of copy number variants in alopecia areata in a Central European cohort reveals association with MCHR2. Exp Dermatol (2016) 0.75
Ultraviolet B, melanin and mitochondrial DNA: Photo-damage in human epidermal keratinocytes and melanocytes modulated by alpha-melanocyte-stimulating hormone. F1000Res (2016) 0.75
Measuring the Impact of Vitiligo: Behind the White Spots. J Invest Dermatol (2016) 0.75
Analysis of telomere length as predictive marker in psoriasis for comorbidities. Exp Dermatol (2016) 0.75
Recessive progressive symmetric erythrokeratoderma results from a homozygous loss-of-function mutation of KRT83 and is allelic with dominant monilethrix. J Med Genet (2016) 0.75
The α7 nicotinic acetylcholine receptor agonist tropisetron counteracts ultraviolet A-mediated oxidative stress in human dermal fibroblasts. Exp Dermatol (2016) 0.75
Genome-wide microRNA analysis implicates miR-30b/d in the etiology of alopecia areata. J Invest Dermatol (2017) 0.75
Pediatric pigmented Spitz nevus: A natural course toward involution assessed with dermoscopy. J Am Acad Dermatol (2016) 0.75
Clinical Significance of Serum Soluble CD Molecules to Assess Disease Activity in Vitiligo. JAMA Dermatol (2016) 0.75
Alterations of CXCL12 in serum of vitiligo patients. J Invest Dermatol (2017) 0.75
Clinically meaningful parameters of progression and long-term outcome of Parkinson disease: An international consensus statement. Parkinsonism Relat Disord (2015) 0.75
Autoantibodies against the calcium-sensing receptor and cytokines in autoimmune polyglandular syndromes types 2, 3 and 4. Clin Endocrinol (Oxf) (2017) 0.75
Increased striatal VMAT2 binding in mice after chronic administration of methcathinone and manganese. Brain Res (2016) 0.75
S100B is a potential disease activity marker in non-segmental vitiligo. J Invest Dermatol (2017) 0.75
Meeting report: Vitiligo Global Issues Consensus Conference (VGICC) Workshop "Outcome measurement instruments" and Vitiligo International Symposium, Rome, Nov 30-Dec 3(rd). Pigment Cell Melanoma Res (2017) 0.75
Defining a Minimal Effective Serum Trough Concentration of Secukinumab in Psoriasis: A Step toward Personalized Therapy. J Invest Dermatol (2019) 0.75
Towards the development of a RNAi-based topical treatment for psoriasis: Proof-of-concept in a 3D psoriasis skin model. Exp Dermatol (2017) 0.75
Melanoma-associated leukoderma and vitiligo cannot be differentiated based on blinded assessment by experts in the field. J Am Acad Dermatol (2016) 0.75
Safety of Systemic Agents for the Treatment of Pediatric Psoriasis. JAMA Dermatol (2017) 0.75
Repigmentation in vitiligo: position paper of the Vitiligo Global Issues Consensus Conference (VGICC). Pigment Cell Melanoma Res (2016) 0.75
Photoprotection and vitamin D. Dermatol Ther (2010) 0.75
Clinical Consequences of Antibody Formation, Serum Concentrations, and HLA-Cw6 Status in Psoriasis Patients on Ustekinumab. Ther Drug Monit (2019) 0.75